CM Yogi praises KGMU's pivotal role in UP's timely Covid-19 response
Yogi Adityanath
on Monday praised King George's Medical University (KGMU) for its pivotal role in responding to the Covid-19 outbreak, marking the beginning of the state's timely and effective pandemic response.
"It was here that testing for the first 100 suspected Covid-19 patients began, making it the first institution in Uttar Pradesh to initiate the tests," said the CM, who was in KGMU to inaugurate and lay the foundation of seven major projects worth Rs 941 crore. The also announced the establishment of a centre of excellence in medical technology at KGMU in collaboration with IIT-Kanpur.
Addressing the gathering, CM Yogi highlighted the state's commitment to future-ready medical infrastructure and innovation.
"The aim is to involve institutions like KGMU and SGPGI in pioneering research that will help make India self-reliant in healthcare technology," he said.
"These enhancement projects represent more than just infrastructure development, they mark the beginning of a new era in our journey towards a 'Healthy Uttar Pradesh, Strong India,'" Yogi said.
The CM called it a landmark moment for any medical institution, stating that projects worth nearly Rs 1,000 crore reflect the double-engine govt's strong commitment to building world-class healthcare infrastructure in UP.
Emphasizing India's health sector improvement, he said, "Over the past 11 years, India achieved unprecedented growth across all sectors, including healthcare."
He said that KGMU pioneered medical advancements in critical times and is now adopting technology to shape the future.
The CM said KGMU has added a remarkable chapter to its 120-year legacy, emerging as a symbol of medical excellence and national service.
Yogi further noted that the number of AIIMS institutes across the country has increased to 23, and UP is making steady progress with its vision of establishing 75 medical colleges in 75 districts. "In 2024 alone, MBBS courses commenced in 17 new medical colleges, 13 of which are govt-run, marking a major transformation in the state's healthcare system aimed at benefiting the common man," he said.
Highlighting the healthcare expansion in Purvanchal, he said that advanced treatments for diseases like dengue and encephalitis were earlier limited to Lucknow.
Now, facilities like platelets and dialysis are available in every district.
Yogi also announced the setting up of a KGMU satellite centre in Balrampur, saying it's time for metro-level healthcare services to reach smaller cities. This step will reduce the burden on major hospitals in Lucknow and allow patients to receive treatment closer to home.
Expressing satisfaction after interacting with patients, CM Yogi said patient trust is the most valuable asset of any institution.
"It's not a small thing when a patient's confidence itself becomes a part of their healing. I saw that trust in the eyes of patients at KGMU," he remarked.
Concluding his address, he urged doctors and healthcare administrators to remain forward-thinking and stay updated with changing times. "Whether it's an individual or an institution, those who fail to evolve with time are left behind. But those who move forward become a source of inspiration," he said.
Earlier, Yogi inspected the newly launched facilities, interacted with doctors, and visited various wards to check on patients.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
19 minutes ago
- Hans India
PLI schemes attract Rs 1.76-trn investments, churn 12 lakh jobs
New Delhi: The production-linked incentive (PLI) schemes have realised actual investment of Rs1.76 lakh crore till March 2025 across 14 sectors, which has resulted in incremental production/sales of over Rs16.5 lakh crore and employment generation of over 12 lakhs (direct and indirect), the Parliament was informed on Tuesday. To date, 806 applications have been approved under PLI schemes across 14 sectors. These schemes have incentivized domestic manufacturing, leading to increased production, job creation and a boost in exports, said Minister of State for Commerce and Industry, JitinPrasada, in a written reply to the Lok Sabha. The pharmaceuticals sector has witnessed cumulative sales of Rs2.66 lakh crore which includes exports of Rs1.70 lakh crore achieved in the first three years of the scheme. The scheme has contributed to India becoming a net exporter of bulk drugs (Rs2,280 crore) from net importer (-1,930 crore) as was the case in FY 2021-22. It has also resulted in significant reduction in gap between the domestic manufacturing capacity and demand of critical drugs. Under the PLI Scheme for medical devices, 21 projects have started manufacturing of 54 unique medical devices, which include high end devices such as Linear Accelerator (LINAC), MRI, CT-Scan, Heart Valve, Stent, Dialyzer Machine, C-Arm, Cath Lab, Mammograph, MRI Coils, etc, the minister informed the House. The production of mobiles in value terms has increased by around 146 per cent from Rs 2,13,773 crore in 2020-21 to Rs 5,25,000 crore in 2024-25 as per industry association and DGCIS. During the same period, exports of mobile phones in value terms has increased by around 775 per cent from Rs 22,870 crore in 2020-21 to Rs 2,00,000 crore in 2024-25, he added. 'Cumulative incentive amount of Rs 21,534 crore have been disbursed as on 24.06.2025 under PLI Scheme for 12 sectors, namely Large Scale Electronics Manufacturing (LSEM), IT Hardware, Bulk Drugs, Medical Devices, Pharmaceuticals, Telecom & Networking Products, Food Processing, White Goods, Drones & Drone Components, Specialty Steel, Textile products and Automobiles & Auto components, the minister highlighted.
New Indian Express
2 hours ago
- New Indian Express
Riding high on life: techie cycles from city to Srinagar during Indo-Pak conflict
Poets, saints, travellers and even mythical rulers across centuries have made the journey mapping the length of this country – people who were in search of adventure, knowledge, spiritual clarity, or perhaps the feeling that comes when you are alone with yourself, confronted by all that you are, all that you fall short of and all that you wish to be. It seems to be the latter for Vivek Anandan, a techie who recently bicycled 3,200 kilometres alone from Bengaluru to Srinagar as a part of a mission to reclaim his life after quitting alcohol. Anandan recounts the hurricane raging inside his mind as he traversed cities, forests, and deserts, saying, 'I was carrying a lot of resentment inside me, especially towards my family, who had suggested rehab. I could not accept that they did it for my sake, so that I could be a good human being, father, and husband. I was quite emotional. Sometimes I would cry on the road thinking about everything that had happened. The trip was a cathartic experience.' The catharsis started at a rehab in 2024. Anandan left the centre in October, determined to turn things around. With unwavering support from his family, he returned to his long-time love for bicycling. 'Since 2008, I used to cycle to work every day and was a part of riding communities. On weekends, we used to ride over 100km to places like Nanjangud, Nandi Hills and Hoskote. I even did a peninsular ride through major places in South India,' he says. Things came to a head during the Covid pandemic's work-from-home shift when he started drinking more. 'Alcohol started consuming me,' he smiles. With time to reset and reboot during rehab, he began to long for the joy of riding again. Once he was out, he started training regularly. 'My wife motivated me, reminding me that cycling is my happy medicine. I started cycling every day on scenic roads, sometimes 70 km and sometimes 100 km. My best was 230, much more than my drinking days,' he says, adding that he would end up covering 1,000 to 1,500 km each month.
Time of India
3 hours ago
- Time of India
Researchers develop glucose monitoring device that doesn't need a finger prick
Prayagraj: Researchers at MNNIT Prayagraj, in partnership with Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, have made a significant breakthrough in medical technology. They've developed a pioneering glucose monitoring sensor that does away with painful needle pricks. Instead, it uses electromagnetic technology to track blood sugar levels in real-time without requiring blood samples. The sensor, designed to be placed between the joint of the thumb and first finger, works in two parts: A sender and a receiver. The sender emits radio waves, which pass through the skin and are then captured by the receiver. By analysing changes in the electrical frequency, the device accurately determines the glucose level — all without a single drop of blood being drawn. The innovation was developed by researchers from the Department of Electronics and Communication Engineering (ECE) at MNNIT, including Prof VS Tripathi and his research students Piyush Mishra and Tilakdhari Singh, in collaboration with Dr Shiv Shankar Tripathi and Dr Swagat Mahapatra from RMLIMS. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like People Aged 50-85 With No Life Insurance Could Get This Reassured Get Quote Undo Their research was published in the Defence Science Journal and the technology has already received a patent. The scientists explained that electromagnetic waves travel from one medium to another, and by measuring changes in frequency, the sensor can detect glucose levels. Since every liquid has its own distinct electrical properties of dissolved sugar level (which is known by a standard mathematical model), the blood between the skin and flesh too has a dielectric constant, allowing the sensor to easily measure sugar levels without interference from bone. "We just connect the device and the changes in the frequency of the electromagnetic waves will provide the precise reading without a single prick or any pain thereof," said Prof Tripathi. This non-invasive sensor offers continuous glucose monitoring, making diabetes management easier and less painful. According to Prof Tripathi, the technology will be especially useful for patients who require frequent monitoring, as it allows for real-time tracking and timely treatment. Importantly, the sensor is also designed to be cost-effective. With an expected retail price of no more than Rs 500, it could be a game-changer in diabetes care, particularly for those from lower-income groups. The compact size of the sensor makes it highly portable and user-friendly, ensuring that patients can carry and use it conveniently anywhere. The project received financial support of Rs 8.94 lakh from the Council of Science and Technology, Uttar Pradesh. With this innovation, the research team took a major step toward making modern diabetes care more accessible, affordable, and comfortable.
